Are there more tricks in the bag for treating thrombocytopenia?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20972327.
- Also identified by DOI 10.1172/JCI45179 and PMC identifier 2965007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thrombocytopenia, an abnormally low number of circulating platelets, results from inadequate platelet production, splenic platelet sequestration, or accelerated platelet clearance. Platelet transfusions are now the cornerstone for treating thrombocytopenia. With an ever-expanding demand for platelets, and with many patients having an inadequate response to platelet transfusions, new strategies are needed to treat thrombocytopenia. In this issue of the JCI, Fuentes et al. present provocative data regarding the use of direct megakaryocyte infusions as a novel approach to manage this vexing clinical problem.
Medical subject headings
- Megakaryocytes
- Platelet Transfusion
- Thrombocytopenia